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Abstract
Introduction Fear of cancer recurrence (FCR) in people with breast cancer affects treatment recovery, quality of life, service
utilisation and relationships. Our aim was to investigate how specialist breast cancer nurses (SBCN) respond to their patients’
fears of cancer recurrence and analyse SBCN’s views about embedding a new psychological intervention, the Mini-AFTERc,
into their consultations.
Method A mixed methods sequential design was used, informed by normalisation process theory. Phase 1: UK SBCNs were
emailed a web-based survey to investigate how breast cancer survivors’ FCR is currently identified and managed, and their
willingness to utilise theMini-AFTERc. Phase 2: a purposive sample of respondents (n = 20) were interviewed to augment phase
1 responses, and explore views on the importance of addressing FCR, interest in theMini-AFTERc intervention, its content, skills
required and challenges to delivering the intervention.
Results Ninety nurses responded to the survey. When SBCN’s were asked to identify the proportion of patients experiencing
FCR in their caseload, there was no consensus on the size of the problem or unmet need. They estimated that 20–100% people
experience moderate FCR and 10–70% severe FCR. The interviews identified that clinical conversations are focused primarily
on giving information about signs and symptoms of recurrence rather than addressing the psychological aspects of fear.
Conclusion Findings indicate wide variability in how FCR was identified, assessed and supported by a sample of UK SBCNs.
The introduction of a structured intervention into practice was viewed favourably and has implications for nursing and health
professional ways of working in all cancer services.
Keywords Breast cancer . Fear of cancer recurrence . Normalisation process theory . Mixed methods . Mini-AFTERc
intervention . Nurse . Nurse specialist
Introduction
Survival outcomes for people with breast cancer have improved
globally over the past 20 years [1]. Despite this, people remain at
risk of metastatic recurrence (local and distant) up to, and be-
yond, 20 years after diagnosis [2]. The risk is strongly correlated
with the original tumour, nodal status and tumour grade. The
uncertainty of this risk enables fears of cancer recurrence to be-
come established among breast cancer survivors [3–6].
Fear of cancer recurrence (FCR) is defined as Bfear, worry,
or concern about cancer returning or progressing^ [3]. It is a
natural response to a cancer diagnosis and experienced on a
continuum from none to severe [6]. It is one of the most
frequent unmet needs reported in the immediate post-
treatment phase [7]. When severe, it can lead to distress, dif-
ficulty coping and poorer physical health [8], leading many to
seek help from clinicians such as doctors and specialist breast
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s00520-019-04762-9) contains supplementary
material, which is available to authorized users.
* Susanne Cruickshank
Susanne.cruickshank@stir.ac.uk
1 Faculty of Health Sciences and Sport, University of Stirling,
Stirling FK9 4LA, Scotland
2 College of Health and Human Sciences, Swansea University,
Swansea SA2 8PP, UK
3 School of Health Sciences, University of Surrey, Guildford GU2
7XH, UK
4 National Cancer Research Institute, Angel Building 407 St John
Street, London EC1V 4AD, UK
5 School of Medicine, University of St Andrews, St Andrews KY16
9TF, UK
Supportive Care in Cancer
https://doi.org/10.1007/s00520-019-04762-9
cancer nurses [9–12]. FCR can be exacerbated once treatment
is complete due to ongoing side effects, and can increase
healthcare usage as women seek reassurance in distinguishing
between recurrence and treatment-related bodily change or
symptoms [13, 14].
A recent systematic review [15] highlighted the need for
interventions to assist people with cancer to manage their in-
creased levels of fear and a number of intensive psychological
interventions have been developed, e.g. AFTER [16],
CONQUER [17], SWORD [18]. Whilst there is some evi-
dence of their effectiveness in people with severe FCR, they
are resource intensive and therefore availability may be limit-
ed. Given the large numbers diagnosed with breast cancer, and
approximately 30–70% experiencing moderate to severe
FCR, nurses, clinical psychologists and psychiatrists need to
find ways to utilise their different skills to address this increas-
ing concern [15]. Humphris developed a shorter version of the
AFTER intervention—the Mini-AFTERc. It consists of a sin-
gle 30-min structured phone call designed to be made by a
specialist breast care nurse (SBCN) instead of the six session
AFTER intervention. Whilst not eradicating FCR completely,
it aims to reduce it to a level that does not significantly inter-
fere with daily life [19]. TheMini-AFTERc consists of a set of
recommended questions to assess relevant issues related to
FCR triggers, intensity, frequency and consequences. Once
this brief assessment is completed, the SBCN selects one or
more to (a) ascertain its significance and impact on the pa-
tients’ everyday life, (b) the nature of the symptom(s), (c)
triggers of FCR following treatment and (d) identifying po-
tential confidantes in the family or friends, and/or if there are
difficulties discussing fears. Our previous experience [19]
found that typically a single aspect is highlighted for attention
during the phone call; however, additional issues can also be
raised. The Mini-AFTERc manual provides written instruc-
tion, with diagrammatic figures to aid comprehension and
includes a number of examples. We are currently conducting
a pilot Mini-AFTERc at four cancer centres (HIPS/17/57).
In many countries, SBCNs, or clinicians in similar roles,
are key providers of emotional and psychological support in
clinical practice and may witness daily expressions of FCR by
women with breast cancer [20–22]. Nevertheless, it is unclear
how SBCNs identify, support and address concerns of people
with FCR in their daily work and if they view this as part of
their role. Moreover, prior to assessing the efficacy of the
Mini-AFTERc, we decided it would be prudent to ascertain
whether SBCNs believe and have the capacity to deliver it as
part of their clinical practice [23].
The aim of this study was to determine the SBCN views on
implementing the Mini-AFTERc intervention into their prac-
tice. The objectives were to:
1. Capture current approaches used by SBCNs to identify
and manage FCR
2. Identify challenges and barriers experienced by SBCNs
in assessing and managing FCR
3. Assess SBCNs willingness to implement the Mini-
AFTERc intervention and understand what would en-
able successful implementation
Methods
Study design
We conducted a sequential explanatory mixed methods
study. Detailed information on the study design and
protocol has been published previously [24]. This de-
sign has two phases: (1) Quantitative survey and (2)
qualitative interviews. The qualitative data were collect-
ed subsequent to the quantitative data to elaborate on
the survey responses in the first phase [25]. The overall
design was informed by normalisation process theory
(NPT). NPT seeks to identify the component parts for
understanding and evaluating the implementation pro-
cess that enable an intervention (e.g. Mini-AFTERc)
not only to be operationalised and normalised into ev-
eryday work (embedded), but also sustained in practice
(integration) [26]. It comprises four key constructs: (a)
coherence, the sense-making work people do when
faced with a new set of practices; (b) cognitive partici-
pation, the relational work people do to build and sus-
tain a community of practice around a new technology
or complex intervention; (c) collective action is the op-
erational work people do to enact a set of practices; and
(d) reflexive monitoring, the appraisal activity people do
to assess and understand how new set of practices affect
themselves and others.
In phase 1, a web-based survey using the Bristol online
survey tool [27] was emailed to health professionals, between
November 2017 and February 2018, who were registered with
Breast Cancer Care’s Nursing UK Network [28].
In phase 2, semi-structured telephone interviews with
SBCNs who indicated a willingness to be interviewed on the
survey were completed. Prior to interview, an information
pack about the Mini-AFTERc was distributed to participants,
including an online presentation and extracts from the manual.
The interview explored in-depth survey responses and, in par-
ticular, the importance of addressing FCR in clinical consul-
tations, interest in the Mini-AFTERc intervention, skills re-
quired and challenges to intervention delivery.
The study was approved by the University of Stirling’s
Research Ethics committee (SREC 15/16-paper no.65). To
maintain confidentiality and anonymity of survey participants,
Breast Cancer Care UK [28] distributed the survey via email.
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Participants
Clinicians registered with Breast Cancer Care’s Nursing
Network (n = 905) were invited by email to complete the sur-
vey, of which 65% are estimated to be SBCNs (n = 588). A
prerequisite of joining the network is that a clinician must
spend 50% of their time working with people with breast
cancer. There is no UK national SBCN register but, based
on 50,000 new breast cancer cases in the UK, and the recom-
mendation of one SBCN for every 100 people diagnosed, this
network appears to represent most of them.
Data saturation (i.e. no new themes/issues raised) was
achieved after 16 interviews. However, we continued to 20
(planned sample size) to ensure maximum variation on the
sample. We developed a purposive sampling matrix
(Online Resource 1) that ensured maximum variation in age,
clinical focus, likelihood, or not, of discussing FCR with peo-
ple and how comfortable, or not, they were discussing FCR.
Phase 1: web-based survey
SBCNs were asked to complete a 35-item survey. The survey
was divided into three sections. Questions 1–14 collected demo-
graphic data, role clarification including proportion of role spent
doing clinical, research, administrative duties, education and
training, and proportion of clinical work providing physical, so-
cial, spiritual and psychological support. Using the FCR defini-
tion [3], questions 15–24 focused on nurses’ perception of the
level of FCR among patients seen in their daily practice, how
they assessed and responded to FCR and how comfortable they
were exploring these concerns. Questions 25–35 asked about
support they received from their team and wider organisation,
their interest in learning to deliver the Mini-AFTERc and their
preferred support and training needs.
Phase 2: qualitative interviews
The topic guide for the semi-structured interviewswas developed
using the normalisation process theory (NPT) framework [26]
(Online Resource 2). Building upon survey responses, questions
focused on the study objectives, whilst aligning these with the
four NPT main components; coherence (e.g. whose responsibil-
ity is it to discuss FCR? Is there a shared sense of purpose to
address FCR among people with breast cancer?), cognitive par-
ticipation (e.g. would the SBCNs be willing to invest time and
energy to attain competence with the intervention, investing time
and energy), collective action (e.g. how would Mini-AFTERc
affect workload and/or change the relationship between the pa-
tient and the SBCN?) and reflexive monitoring (e.g. questions
about the perceptions of benefit to patient or staff, necessary
requirements to make the intervention workable in practice).
The interviews were conducted by telephone (ES), audio-
recorded and transcribed verbatim.
Data analysis
Survey data were analysed descriptively. Frequencies are pre-
sented as percentages.
All qualitative interviews were managed using NVivo 10
[29]. Framework analysis guided data analysis following a
five step process [30]: (1) reading of the transcripts allowed
for familiarisation with the data; (2) a thematic frame was
developed based on NPT components and issues arising from
the data; (3) the whole data corpus was then coded in relation
to these specific themes; (4) charting of the data was conduct-
ed; and (5) mapping and interpretation of data within and
across the themes allowed for interpretation and analysis.
We utilised the NVivo comparison query [29] to permit ES
to double code 25% of the transcripts to increase rigour and
trustworthiness. ES and SC reviewed quotes and consensus
was achieved on any statements not easily fitting the thematic
framework, and shared them with the research team.
The weighting of the quantitative and qualitative data in a
sequential explanatory design can vary depending on the
study aims [26]. In this study, both were given equal
weighting due to the additional information provided to the
interviewees about the Mini-AFTERc intervention.
Patient and public involvement
The GRIPP2 short form guided our reporting of public in-
volvement (PPI) [31]. Our patient representative and co-
author (EB) and the UK-based patient focused charity,
Breast Cancer Care, shared their experience of supporting
people with breast cancer using their helpline. Concerns about
FCR emerge frequently as a topic women wish to discuss on
their helpline call. This insight helped the researchers develop
and conduct this study. They participated in all research meet-
ings, online communications, and contributed to discussions
that created a consensus among the research team. All itera-
tions of documentation were reviewed and edited by all au-
thors and collaborators.
Results
Phase 1
The invitation email was opened by 314 registrants (35%), of
these 144 clicked on the survey (45%) and 90 completed the
survey (29%). The demographic characteristics of the partici-
pants in both phases are presented in Table 1. Most were >
40 years (90%) and had been qualified > 11 years (91%, n= 82).
When SBCNs were asked to identify the proportion of pa-
tients experiencing FCR in their caseload, there was no con-
sensus as to the size of the problem or unmet need (see Fig. 1).
Over half (n = 52) estimated 60–80% experienced moderate
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FCR (range 20–100%). Estimates for severe FCR were more
conservative with most (n = 72) reporting they believed 10–
30% (range 10–70%) experienced it. Only 14% reported initi-
ating discussions about FCR with all their patients, whilst 45%
said they would only discuss FCR if the patient raised it. Less
than a fifth said they did not feel comfortable discussing FCR
with patients. Most did not use a formal tool to assess FCR
(78%) and reported in a free text box that they generally
assessed FCR through discussion, open questions or informally
at post-treatment clinics. Of 22 who reported using a formal
tool, the most common measures included Macmillan
Concerns Checklist (n = 13), FCR-specific scale (n = 2), de-
partmental tool (n = 2) and other (n = 6). Main barriers to their
use were time and patient compliance.
In the survey responses (Table 2), nurses reported they
responded daily to patients’ concerns through various means.
However, the formal psychological training and support they
received to fulfil their role, and the perceived benefits gained,
varied. Almost 50% reported that, with the exception of sup-
portive team discussions, the benefits of attending clinical
supervision or formalised team discussions were variable.
Clinical supervision was important to some, both alone and
with their team, but not everyone reported it helped them
perform their role better. Of 19% who received training about
FCR, most (n = 16) found it beneficial. When asked about
training preferences to deliver the Mini-AFTERc, most
(67%) were in favour of receiving training. Of these, 84%
preferred face to face delivery, 75%, online delivery and
52% shadowing an experienced practitioner.
Phase 2
The qualitative interviews offered an opportunity to explain
survey responses and additional insights into implementation
of Mini-AFTERc in practice. The thematic coding frame was
informed by NPT (Table 3), and illustrative quotes are provid-
ed below, with further quotes as Online Resource 3.
Coherence
Coherence related to how FCR is raised in practice, timing of
discussion, strategies and, confidence. Some nurses stated
they only discussed the possibility of recurrence if the patient
raised it as a concern, for fear of introducing it into the pa-
tients’ consciousness.
BIt’s all about reassuring. It’s all about everything’s go-
ing to be absolutely fine and to bring in the fact that, oh,
actually, well, you...it might come back, you know, goes
Table 1 Participant demographics—phases 1 and 2
Variable Phase 1: % Survey
respondents (n) n = 90
Phase 2: %
Interviewees (n) n = 20
Age (years) Under 30 1 (1) 0 (0)
30–39 8 (9) 1 (5)
40–49 33 (37) 7 (35)
50–59 40 (44) 12 (60)
60 and over 8 (9) 0 (0)
Number of years qualified as a nurse Less than 2 0 (0) 0 (0)
2–5 0 (0) 0 (0)
6–10 8 (9) 0 (0)
11–20 15 (17) 2 (10)
21–30 36 (40) 11 (55)
Over 30 31 (34) 7 (35)
Number of years working with people affected by breast cancer Less than 2 2–5 2 (2) 8(9) 0 (0) 2 (10)
6–10 16 (18) 3 (15)
11–20 41 (46) 11 (55)
21–30 22 (24) 4 (20)
Over 30 1 (1) 0 (0)
Job banding 5 2 (2) 1 (5)
6 22 (24) 6 (30)
7 50 (56) 7 (35)
8 14 (16) 6 (30)
9 2 (2) 0 (0)
Clinical area Surgery 41 (46) 8 (40)
Oncology 24 (27) 8 (40)
Surgery and Oncology 10 (11) 3 (15)
Oncology and medical 2 (2) 0 (0)
Surgery, oncology and medical 2 (2) 0 (0)
Primary care 1 (1) 1 (5)
Other 10 (11) 0 (0)
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against a lot of what the message that I’d say we’re
trying to get across is how I interpret it^. SBCN12
Those nurses, however, who initiated FCR discussion be-
lieved they were validating a pre-existing concern that most,
if not all, patients already experienced.
As identified in the survey, most disclosed that they felt
comfortable discussing FCR with patients. However, discus-
sion on how SBCNs manage FCR suggested that many may
simply talk about being aware of signs and symptoms of re-
currence, without addressing fear as a psychological entity in
its own right. Indeed, some recognised a need but were un-
clear about how best to act.
BI think my concern is not knowing what I could do
about it. I mean, I can refer people for therapy, for
counselling, but I don’t know that that’s necessarily
the thing that they need. They’re not necessarily de-
pressed or have an anxiety state, they need to know
how to deal with that one particular problem^. SBCN19
Strategies for assessing people’s unmet needs were limited.
When assessment tools were used, most spoke reported using
the BMacmillan concerns assessment tool^ despite it not in-
cluding specific questions about FCR.
BIf there was an HNA [holistic needs assessment] for every
patient who was being discharged to open access [follow-up]
then you could perhaps pick up more cases of FCR through
that way. Unless somebody brings it up at a clinical appoint-
ment, we don’t tend to explore it. Sometimes they do and you
can have a small discussion but the time we have is limited at
the moment^. SBCN 1
Cognitive participation
Cognitive participation explored training, format, aspects and
time investment. Whilst challenges of implementing a new
interventionwere discussed, most nurses welcomed additional
training and saw broader benefit not just to the patient but also
their own working practice:
BIt’s harder now than it used to be back in the day, but I
think if it’s something that is going to be of value and
you feel it is going to be of value professionally. I think
you pick and choose now which you feel is going to be
beneficial to you in your role, and your patient experi-
ence and expectation^. SBCN11
However, the importance of the intervention fitting within
their current working practice was stressed;
BWe wouldn’t have the time to do a separate session, so
we would have to integrate it into something we’re al-
ready doing when we’re already seeing them^. SBCN1
There was no consensus about when to introduce it, to whom
and where;
BI don’t think there’s any particular group that are more
fearful than others. So in an ideal world, it would be
great if everybody was offered this opportunity, but that
would be absolutely impossible because of the number
of breast patients that we see. So whether it could be
something that the BCNs talk about and say, you know,
if at any time in the future you feel as though you’re
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Fig. 1 SBCN estimates of people
with severe/moderate FCR in
their caseload
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feeling particularly concerned, then we can have a more
in-depth conversation^. SBCN2
Collective action
This theme explored changing practice, differences between
theMini-AFTERc and current practice and impact on patients.
Nurses spoke about enhancing practice and raising awareness
of FCR:
BI’m not a hundred per cent sure if it would change
practice greatly. I think it would just make us more
aware of what we need to address^ SBCN 14
Others could envisage quite clearly mutual benefits from the
structured approach, which they saw as acting as a triage tool,
BIt’s a much more structured approach obviously and it
sounds like it has the potential to be able to differentiate be-
tween those patients we think we can help and those that really
need a far more structured intervention or psychologist or
therapist approach^ SBCN13
Reflexive monitoring
This theme explored enablers to successful implementation of
the Mini-AFTERc: timing, using it appropriately and adding
to SBCNs’ skills:
BI think anything that benefits the patients, and makes
the journey easier and also gives us more skills in deal-
ing with recurrence and fear of recurrence has to be
beneficial to both the patients, the nurses, and to the
service^. SBCN16
Table 2 Survey responses from the SBCNs
Different types of work undertaken by SBCNs on a daily basis
% of 90 (n)
Anxiety management 13 (73)
Communicating news 13 (74)
Counselling 8 (46)
Crisis interventions 7 (40)
Supporting clinical choices 15 (84)
Dealing with distress 15 (64)
Information giving 15 (89)
Preparing for treatment 14 (79)
Nurses who report using assessment tools in their daily work
Yes No Maybe
% (n) nurses using a FCR assessment tool 22 (20) 78 (70) n/a
% (n) nurses assessment tools (general) 28 (25) 72 (65) n/a
% nurses who find assessment tools helpful 70 (63) 30 (27) n/a
% (n) nurses willing to attend a Mini-AFTERc training course 74 (67 0 26 (23)
Nurses who report receiving training/support to perform their role
SD CS-1 CS-T ITD FTD FCR-T OPT
% nurses receiving training/support to perform their role 72 (64) 18 (24) 24 (31) 51 (68) 7 (9) n/a n/a
% nurses receiving specific FCR training 21 (19)
Nurses perceived benefits of receiving different support/training to their work
< 50% n > 50% n n/a % n/a n
Support received from team SD 28 25 63 58
One to one/clinical supervision CS-1 20 18 29 24 51 46
Team clinical supervision (CS-T) 20 18 35 31 46 41
Informal team discussion (ITD) 25 23 69 62 7 6
Formalised team discussion (FTD) 17 17 31 31
Specific FCR training (FCR-T) 16 3 73 16
Other focused psychological training (OPT) 72 16 16 3
SD, general support from team;CS-1, clinical supervision/one to one; CS-T, clinical supervision team; ITD, informal team discussion; FTD, formal team
discussion; FCR-T, FCR training; OPT, other psychological training
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Not all nurses felt comfortable and a number mentioned con-
cerns about the intervention being delivered by telephone rath-
er than face to face:
BI would like to use face-to-face, I prefer face-to-face
interventions and I think there is lots of unspoken and
body language and just people’s unspoken behaviours
that tell a story, so I prefer that but I think it would be
useful to have as a phone intervention as well^. SBCN3
Combining the data, Table 4 provides a summary of some of
challenges and solutions that would need to be considered to
optimise a future trial to test efficacy.
Discussion
This is the first study to gather survey and interview data using
sequential explanatory methodology to explore how specialist
breast cancer nurses manage FCR, and strategies they use to
identify those people at risk. It, therefore, highlights some im-
portant issues and enablers that could help embed successful
implementation of this new intervention into SBCNs’ work.
FCR is increasingly reported as an unmet need within the
literature [3–4, 6,-7], although the picture in clinical practice
appears less clear. SBCNs are the professional group who
engage frequently with people affected by breast cancer, pro-
viding a broad range of psychological support [10]. They
Table 3 Thematic coding framework of interview data
NPT Component –Main theme Sub-themes Coding
Coherence
Is the sense making work that people do individually and
collectively when they are faced with a problem of
operationalising some set of practices
Identifying FCR – how it is raised Formal assessment
Not always addressed
Probing for silent concerns
Timing of FCR discussion End of treatment – 6 months
after
On-going
variable
Managing FCR (strategies) Discussing signs and
symptoms
Signposting
Open access follow-up
Confidence Confident
Managing uncertainties
Difficult to raise
Cognitive participation
Is the relational work the people do to build and sustain
a community of practice around a complex
intervention or technology
Training format Face to face
online
Training aspects Action plan
Advanced communication
Willingness to invest time Adding to skillset
Whole BCN team
Collective action
Is the operational work that people do enact a set of practices,
whether these represent a new complex intervention or
technology
Changing practice Enhanced practice
more awareness of FCR
Fits well
Perceived difference between Mini-AFTER and
current practice
More structured and specific
Triaging tool
Helps alleviate fear
Reflexive monitoring
Is the appraisal work that people do to assess and understand
the ways that a new set of practices affect them and others
around them
Workable in practice Timing of discussion
Timing involved
Fitting with other tools
Who would Mini-AFTERc benefit Patients
SBCNS
Patient sustainability Offer to all patients
Which patients would be
suitable
Support Care Cancer
work closely with psychological services but there appears to
be no uniform approach by which they identify and stratify
individuals with low, moderate or high FCR. Very few of the
nurses used any formal tool, leaving much to intuition, expe-
rience and question probing.We found that estimates of level
of FCR are at odds with self-reports from patients which sug-
gest that need for support is not being met [14]. Indeed, this
discrepancy suggests that some people may not be getting the
right support at the right time, potentially compounded by a
lack of systematic approaches to assessment. The Mini-
AFTERc aims to bridge this need in a resource-efficient
manner.
To date, a number of FCR interventions have been de-
signed and tested [14] with most delivered to small numbers
by psychologists and therapists. The care of people with breast
cancer, and specifically psychological support, is not mutually
exclusive to any one professional group. Although the Mini-
AFTERc is a complex intervention based on a theoretical
model with a detailed manual [32], and designed for SBCNs
to deliver in routine practice as part of a stepped care model, it
offers potential to be adapted for use by other professionals in
the future. Tools to identify and manage FCR were not found
to be usual practice and therefore it was significant that nurses
accepted both the intervention itself and also the need to use a
FCR assessment tool in their daily work.
Internationally, breast cancer guidelines recommend that
people are made aware of new signs and symptoms that could
signal a recurrence [33–35]. Some nurses in the interviews
described discussing signs and symptoms of recurrence when
asked about their confidence to discuss FCR. Their responses
indicated an ease with information giving about new signs and
symptoms of recurrence, rather than actively addressing psy-
chological fears associated with the cancer recurring. When
FCR is severe, it can lead to distress, difficulty coping and
poorer physical health [8].
This study also gained insight into the practicality of the
SBCN’s role in the delivery of the Mini-AFTERc and many
were willing to consider it as a workable option that could
be embedded in their practice, an important area to inform
our trial design. Understandably, they reported they would
require training. Listening to their training needs indicated
that face-to-face sessions combined with online support
was the most acceptable method. Prioritising patient care
emerged as the main focus of the SBCNs work and many
viewed the Mini-AFTERc as potentially beneficial to both
their patients and their own professional development.
Table 4 Development and optimisation of Mini-AFTERc intervention/pilot trial using NPT (Adapted from Murray et al. 2010)
NPT components Questions using a NPT approach NPT analysis to improve trial design
Coherence What is the relationship between knowing about FoR is a
concern and identifying how a new intervention aligns
with everyday practice?
The intervention, described in more detail for the interview
participants, was easily understood and distinguishable
from other interventionsthey delivered.
What is the worth attributed to introducing a FoR intervention? Fear of recurrence was a term very familiar to the SBCN
and recognised by many as an area of concern among
patients they meet.
Is the intervention easily described? Perception of the proportion patients with moderate to severe
FCR may be over or under-represented. This indicated a
gap in accuracy in current assessment approaches used
and therefore estimation of perceived benefit.
Is there a shared sense of purpose?
Who would the intervention benefit?
Are benefits likely to be valued by women with breast cancer?
Cognitive participation Are the target groups, people affected with breast cancer,
and SBCNs likely to think it is a good idea?
For SBCN, the trial would provide an opportunity to gain
new skills through protected training and positively viewed.
What kind of skills do SBCNs have now when dealing
with FoR concerns?
It is expected a structured intervention could improve the
confidence of SBCNs
Are SBCN likely to invest time, energy and work into
delivering a FoR intervention?
SBCN’s offered the opportunity to gain psychological training
to deliver a FCR intervention were largely enthusiastic
and likely to invest time to train to do it.
Collective action Will it promote or impede their work? Projected benefits appear to be consistent with their work
Do they think it would change the patient/SBCN relationship? May improve interactions. Uncertainty about how patients
will be approached – training will help
Is the work compatible with the existing practices of the SBCN? High levels of their work are focused on psychological support
although low use of structured cognitive behavioural
approaches
How would the intervention impact on their workload? The SBCNs may need to challenge their current /organisational
practices in the provision of psychological support
How does it fit with organisational goals?
Reflexive monitoring
(reflect on the trial)
How are SBCNs likely to perceive the benefits of the
intervention once it has been used?
SBCN saw the benefits of intervention and understood training
would be delivered. Some held concerns about the
intervention being delivered via telephone and not face to face.
Do they perceive issues associated with recruitment? For SBCN, clear training in identification of participants with
moderate FCR is required
What would be required to make the intervention workable in practice? There are pressures on services so choosing a regular day/time
to deliver intervention will be necessary to encourage
adoption into work schedule
When would be an appropriate time to review the intervention?
Support Care Cancer
Barriers to implementation included time and personal
fears that introducing FCR could trigger anxiety in a person
that was not previously present. Some also felt it conflicted
with the positive, hopeful message about breast cancer so
often portrayed [36] and that many of the nurses felt com-
fortable with.
The strength of this study is our mixed methods design
was informed by NPT as it provided in-depth insights,
before planning our current study, about how and what is
required to test the efficacy of the intervention in clinical
practice including confirmation that there is a high likeli-
hood that nurses can implement the intervention as
planned, they perceive a demand for this type of interven-
tion and it fits within their practice culture and goals. This
step is often overlooked in the development of trials [37],
leading to assumptions being made about roles and rela-
tionships between nurses and patients that either do not
exist or, as we found, are highly variable.
One limitation was our recruitment approach. We relied on
a single email to a mailing list to access SBCNs. This may not
have been a comprehensive list and could have included non
SBCNs. Only one email was sent and we relied on the nurses
both receiving and opening the email. The auto mail sifting or
Bjunk^ function that is embedded in many email programmes
may have affected the number of nurses receiving the email
and negatively influenced our overall responses. However,
this was countered by the benefits of accessing SBCN from
across the UK and in a variety of settings.
In conclusion, theMini-AFTERc was designed specifically
for patients who have completed their primary treatment for
breast cancer; with minor alterations, we consider this inter-
vention suitable for patients with other forms of cancer. By
exploring views of SBCNs, a picture has emerged about how
FCR conversations arise in their day-to-day work. Practices
differ markedly and the self-reported skill and confidence of
nurses to raise and/or respond to patients’ concerns in this area
was variable. Although SBCNs recognise FCR as important
and a frequent cause of distress among patients, actual tech-
niques that assist patients manage and cope with FCR are
limited. This is potentially compounded by little use of assess-
ment tools that ask specifically about FCR. Nevertheless,
SBCN expressed an interest, and willingness, to learn about
the Mini-AFTERc to enhance their skills.
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